The PRISMAP consortium has launched its first open call for projects, with a deadline for applications of 31 March 2022.
PRISMAP is a European medical radionuclide program on the production of high-purity radionuclides and brings together a consortium of 23 beneficiaries from 13 countries. The organization offers a single-entry point for researchers who are seeking to develop innovative radionuclides of high-purity grade for medical applications.
The group encouraged those interested to follow the submission guidelines, complete the application form, and upload their project description to its online platform. Awardees will receive access to PRISMAP's production and medical facilities and the currently available radionuclides.
